Evidence map›Paper›PMID 40018588›Full record

ArticleBMJ public health2024

Machine learning to evaluate the relationship between social determinants and diabetes prevalence in New York City.

Darren Tanner, Yongkang Zhang, Ji Eun Chang, Peter Speyer, Elizabeth Adamson, Ann Aerts, Juan M Lavista Ferres, William B Weeks

Abstract read
In one paragraph

Article in BMJ public health, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. CARDIO4Cities: A roadmap for improving urban cardiovascular health.American journal of preventive cardiology · 2026
    Article
  3. Machine Learning Based County Level Phenotypes Related to Diabetes Prevalence.AMIA Joint Summits on Translational Science proceedings. AMIA Joint Summits on Translational Science · 2026
    Article
  4. Review
  5. Using AI to Improve Individual and Population Health.International journal of public health · 2026
    Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Darren TannerAI for Good Research Lab, Microsoft Corp, Redmond, Washington, USA.ORCID 0000-0003-0805-0494
Yongkang ZhangDepartment of Population Health Sciences, Weill Cornell Medicine, New York, New York, USA.
Ji Eun ChangNew York University School of Global Public Health, New York, New York, USA.
Peter SpeyerNovartis Foundation, Basel, Switzerland.
Elizabeth AdamsonNovartis Foundation, Basel, Switzerland.
Ann AertsNovartis Foundation, Basel, Switzerland.
Juan M Lavista FerresAI for Good Research Lab, Microsoft Corp, Redmond, Washington, USA.
William B WeeksAI for Good Research Lab, Microsoft Corp, Redmond, Washington, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Diabetes is a leading contributor to cardiovascular disease and mortality; social determinants of health (SDOH) are associated with disparities in diabetes risk. Quantifying the cumulative impact of SDOH and identifying the SDOH most associated with diabetes prevalence at the neighbourhood level can help policy-makers design and target local interventions to mitigate these disparities. Machine learning (ML) methods can provide novel insights and help inform public health intervention strategies in a place-based manner. Methods: In a cross-sectional study, we used gradient boosting ML models to estimate the cumulative contribution of a set of SDOH variables to diabetes prevalence (%) at the census tract level within New York City (NYC); Shapley Additive Explanations were used to assess the magnitude and shape of relationships between our SDOH variables and model-predicted NYC diabetes prevalence. SDOH measures included socioeconomic position, educational attainment, food access, air quality, neighbourhood environment, housing conditions and insurance coverage. Results: Across 2096 NYC census tracts (population 8 170 505), mean diabetes prevalence was 11.5% (SD 3.7%; range 1.9%-42.8%). A set of 16 SDOH variables representing a framework of 16 distinct SDOH concepts accounted for 67% of the between-tract variance in model-derived NYC diabetes prevalence estimates (95% CI 66% to 68%); a set of 81 variables representing these 16 concepts accounted for 80% of variance (95% CI 78% to 81%). Models showed excellent across-location generalisation. The most important variables driving model predictions within NYC were measures of low educational attainment and poverty. Conclusions: SDOH accounted for a substantial proportion of neighbourhood-level variation in diabetes prevalence within NYC, independent of the demographics and health behaviours associated with those SDOH. Our place-based findings suggest that, within NYC, where approximately one million residents have diabetes and there are legislative requirements to reduce the impacts from diabetes, policies reducing socioeconomic and educational inequality could have the greatest potential to equitably achieve this.

Indexed as

Cross-Sectional StudiesPublic HealthSocial MedicineSociodemographic Factorsstatistics and numerical data

Identifiers

PMID40018588
PMCPMC11816513

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.